GGrantIndex
Sort

78,016 grants matching breast cancer

Symptom Management After Breast Cancer Surgery

$1,062,010
Christine A. Miaskowski · University Of California, San Francisco · R01 · FY2007 · CA

TARGETING P38GAMMA FOR THE TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER

$1,061,883
The Medical College Of Wisconsin, Inc. · · FY2015 · Department of the Army

Clinical Evaluation of a Personalized Vaccine Immunotherapy in Combination with Checkpoint Inhibitors for Triple Negative Breast Cancer

$1,061,403
Christopher D Pack · Metaclipse Therapeutics Corporation · R44 · FY2021 · CA

Discovery and verification of novel biomarkers of colorectal cancer recurrence

$1,061,342
Christopher I Li · Fred Hutchinson Cancer Research Center · R01 · FY2017 · CA

TARGETING PCD FOR CANCER THERAPY

$1,061,323
University Of Michigan At Ann Arbor · P01 · FY2001 · CA

Center of Biomedical Research Excellence in Matrix Biology Phase 3

$1,061,250
Julia T Oxford · Boise State University · P30 · FY2024 · GM

Center of Biomedical Research Excellence in Matrix Biology Phase 3

$1,061,250
Julia T Oxford · Boise State University · P30 · FY2025 · GM

Discovery and verification of novel biomarkers of colorectal cancer recurrence

$1,061,207
Christopher I Li · Fred Hutchinson Cancer Research Center · R01 · FY2018 · CA

Targeting intratumor heterogeneity in breast cancer

$1,060,812
Kornelia Polyak · Dana-Farber Cancer Inst · R35 · FY2025 · CA

Targeting intratumor heterogeneity in breast cancer

$1,060,812
Kornelia Polyak · Dana-Farber Cancer Inst · R35 · FY2022 · CA

VANGUARD CENTER FOR WOMENS HEALTH INITIATIVE

$1,060,798
Fred Hutchinson Cancer Research Center · N01 · FY2000 · WH

TARGETING TRYPTOPHAN CATABOLISM: A NOVEL METHOD TO BLOCK TRIPLE NEGATIVE BREAST CANCER METASTASIS.

$1,060,648
The Regents Of The University Of Colorado · · FY2015 · Department of Defense

Fred Hutchinson Breast Cancer Clinical Validation Center

$1,060,017
Christopher I Li · Fred Hutchinson Cancer Center · U01 · FY2023 · CA

Sioux Community Cancer Consortium

$1,060,000
Loren K Tschetter · Sanford Clinic · U10 · FY2006 · CA

TGF-betas in breast cancer progression

$1,059,250
Lalage Wakefield · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

SBIR Phase II: Electrical Property Detection of Residual Cancer in the Surgery Suite

$1,059,148
William D Gregory · Novascan Llc · · FY2011 · TIP

NATURAL KILLER CELL-MEDIATED TARGETING OF IGF1R AND IR-A IN HORMONE RECEPTOR-POSITIVE BREAST CANCER

$1,059,132
Regents Of The University Of Minnesota · · FY2025 · Defense Health Agency

Enhancing Native American Participation in RT Trials

$1,058,891
Rapid City Regional Hospital · U56 · FY2005 · CA

METROPOLITAN NEW YORK REGISTRY OF BREAST CANCER FAMILIES

$1,058,409
Columbia University Health Sciences · U01 · FY2005 · CA

Leveraging DNA damage repair pathways as therapeutic targets in womens cancers

$1,058,087
Jung-Min Lee · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Collaborative Protein Technology Resource - Nano-Scale Protein Analysis Section

$1,057,804
Jinqiu Chen · Division Of Basic Sciences - Nci · ZIC · FY2020 · CA

Mechanisms of the Hormonal Prevention of Breast Cancer

$1,057,696
Baylor College Of Medicine · P01 · FY2004 · CA

Columbus NCORP RFA-CA-18-016

$1,057,540
William A Wilson · Columbus Community Clinical Oncology Prg · UG1 · FY2024 · CA

STARLIGHT, The Next Generation X-ray Imaging Technology

$1,057,480
Eric Silver · Imagine Scientific, Inc. · R44 · FY2022 · CA

Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer

$1,057,469
Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA